2.

Global Fund Board approves additional funding worth $57.9 million through portfolio optimization, for grants in five countries

29 Apr 2020
More funding for Algeria, Ethiopia, Ghana, Nigeria, and Uzbekistan for HIV, malaria, and tuberculosis

The Global Fund Board has approved $57.9 million to finance interventions listed on the Register of Unfunded Quality Demand (UQD) for existing grants in five countries: Algeria (HIV), Ethiopia (TB), Ghana (malaria), Nigeria (TB), and Uzbekistan (TB) grants. The additional funding comes from the reallocation of unutilized funds from other existing Global Fund grants to other countries, termed ‘portfolio optimization’.  

4.

Global Fund has allocated an additional $43.3 million to existing grants in several countries for 'portfolio optimization'

18 Mar 2020
Funding goes to Kosovo, Middle East Response, Namibia, Nigeria, South Sudan, and Zambia

1.

Global Fund Board approves $135.7m and €25.7m of portfolio-optimization awards for 23 countries

25 Feb 2020
$2.6m from private sector to be integrated into Papua New Guinea malaria grant

2.

All funding requests to the Global Fund for 2017-2019 reviewed by TRP, most approved by the Board

21 Aug 2019
Virtually all of $20 million set aside for emergencies has been awarded

As of 1 July 2019, the Technical Review Panel (TRP) has completed its reviews of funding requests for the 2017-2019 allocations and has issued recommendations covering all of the funds available for country allocation ($10.3 billion); all of the matching funds that were subject to TRP review ($313 million); and all of the funds earmarked for multi-country grants ($260 million).

1.

Global Fund Board approves new country and multi-country grants valued at $47.3 million

20 Aug 2019
Interventions from the UQD Register worth $42.2 million also approved

On 16 August 2019, by electronic vote, the Global Fund Board approved funding for three country grants worth $32.7 million (Colombia HIV, Honduras TB/HIV and Kazakhstan TB). Domestic commitments for the programs included in the approved country grants amounted to $1.17 billion. Initiatives valued at $2.4 million were added to the Unfunded Quality Demand (UQD) Register. (See Table 1.)

1.

Global Fund Board approves initiatives worth $18 million from the Unfunded Quality Demand Register

31 Jul 2019
A private sector contribution of $2 million will support RAI grant in Southeast Asia; others through portfolio optimization

On 24 July 2019, the Global Fund Board approved funding in the amount of $18.0 million from the 2017-2019 allocations for several interventions on the Unfunded Quality Demand (UQD) Register. The funds will be added to three existing country grants and one existing multi-country grant. The sources of these funds are portfolio optimization and a private sector contribution. (See Table 1 below.)

2.

Global Fund invests $40 million to facilitate $400-million World Bank loan to India

26 Jun 2019
Loan ‘buy-down’ leverages increased resources to frontload India’s investment, help achieve impact quickly

The Global Fund describes the $41.6 million in funding awarded to India in April as an innovative approach that will catalyze significant additional funding for the fight against tuberculosis. The award includes $40.0 million to buy down a portion of a $400.0-million loan from the World Bank over five years.

1.

Global Fund Board approves new country and multi-country grants along with interventions on UQD Register

27 May 2019
Largest single award was $13.2 million for a Burkina Faso malaria grant

On 13 May 2019, the Global Fund Board approved, by electronic vote, funding for five country grants having a total value of $25.2 million. Domestic commitments for the programs included in the approved country grants amounted to $937.9 million. The five country grants were for four countries: Gabon, Georgia, Peru and Serbia. The largest award ($9.3 million) was for a Georgia HIV grant. (See Table 1 for details.)

4.

Global Fund Board approves $590 million for country grants

30 Apr 2019
Largest single award was for a South African TB/HIV grant
Domestic commitments for the programs included in the country grants amounted to $7.5 billion
1.

Global Fund Board approves a small 18th batch of grants from 2017-2019 allocations

2 Apr 2019
Egypt, a non-CCM applicant, receives funding for a new TB/HIV grant

On 22 March 2019, the Global Fund Board approved funding for two country grants and supplementary funding for a third –– for a total value of $11.0 million. Interventions worth $4.1 million were added to the Unfunded Quality Demand (UQD) Register. Domestic commitments for the programs included in the approved country grants amounted to $28.5 million. (See Table 1 for details.)

Pages